Kuster Introduces Bipartisan, Bicameral Bill to Lower Prescription Drug Costs by Cracking Down on Abuses of Medication Patent Process
September 13, 2023
September 13, 2023
WASHINGTON, Sept. 13 -- Rep. Ann Kuster, D-New Hampshire, issued the following news release:
Congresswoman Annie Kuster (NH-02), alongside Senators Maggie Hassan (D-NH) and Mike Braun (R-IN) as well as Representative Diana Harshbarger (TN-01), introduced bipartisan, bicameral legislation to lower prescription drug costs by closing oversight gaps that drug manufacturers take advantage of.
Because of incomplete coordination between the Food and Drug Administration (FDA) . . .
Congresswoman Annie Kuster (NH-02), alongside Senators Maggie Hassan (D-NH) and Mike Braun (R-IN) as well as Representative Diana Harshbarger (TN-01), introduced bipartisan, bicameral legislation to lower prescription drug costs by closing oversight gaps that drug manufacturers take advantage of.
Because of incomplete coordination between the Food and Drug Administration (FDA) . . .